ICU sedation

Revision as of 19:15, 15 June 2015 by Kian (talk | contribs) (ICU sedation page started)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Background

  • Sedation is commonly used for ICU patients
  • Agent choice determined by side effect profile and disease process

Uses

  • Can control agitation
  • Improves patient-ventilator synchrony
  • Decreases O2 consumption
  • Decrease intracranial pressure in neurosurgical patients

Agents

Adverse Effects

  • Drug and dose dependent, but generally include:
    • Hypotension
    • Respiratory depression
    • Withdrawal
    • Delirium
    • Arrhythmias

Monitoring

  • Several sedation monitoring scales are validated
  • Richmond Agitation and Sedation Scale most commonly used (RASS)
    • Lighter sedation associated with shorter ICU stay, decreased time on ventilator[1]

Considerations

  1. Jacobi, J., Fraser, G. L., Coursin, D. B., Riker, R. R., Fontaine, D., Wittbrodt, E. T., Chalfin, D. B., Masica, M. F., Bjerke, S. H., Coplin, W. M., Crippen, D. W., Fuchs, B. D., Kelleher, R. M., Marik, P. E., Nasraway, S. A., Murray, M. J., Peruzzi, W. T. and Lumb, P. D. (2002) ‘Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult’, Critical Care Medicine, 30(1), pp. 119–141.